Hara Capital LLC purchased a new position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,943 shares of the company’s stock, valued at approximately $832,000.
Other large investors also recently made changes to their positions in the company. Fountainhead AM LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 3rd quarter worth $204,000. AlphaStar Capital Management LLC acquired a new stake in shares of BlackRock Health Sciences Trust during the 4th quarter worth $878,000. Janney Montgomery Scott LLC increased its holdings in shares of BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares during the last quarter. Consolidated Portfolio Review Corp increased its holdings in shares of BlackRock Health Sciences Trust by 7.2% during the 3rd quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock worth $1,785,000 after buying an additional 2,853 shares during the last quarter. Finally, Wolverine Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Trust by 42.4% during the 3rd quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock worth $3,588,000 after buying an additional 25,457 shares during the last quarter.
BlackRock Health Sciences Trust Stock Performance
BME stock opened at $40.17 on Tuesday. BlackRock Health Sciences Trust has a 52 week low of $36.87 and a 52 week high of $42.73. The business has a fifty day simple moving average of $39.26 and a 200-day simple moving average of $40.43.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Trust
- Options Trading – Understanding Strike Price
- AMC Stock Surges on Bitcoin News—Meme Stocks Making a Comeback?
- How to Use the MarketBeat Stock Screener
- Hims & Hers: From Viral Ad to Volatile Stock
- Do ETFs Pay Dividends? What You Need to Know
- Beyond DeepSeek: 4 Chinese ETFs for AI & Tech Exposure
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.